Combination of Limosilactobacillus fermentum MG4231 and MG4244 attenuates lipid accumulation in high-fat diet-fed obese mice
Open Access
- 11 October 2021
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 12 (5), 479-492
- https://doi.org/10.3920/bm2020.0205
Abstract
We investigated the anti-obesity effect and the underlying mechanisms of action of human-derived Limosilactobacillus fermentum MG4231, MG4244, and their combination, in high-fat diet-induced obese ...This publication has 61 references indexed in Scilit:
- Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese MicePLOS ONE, 2013
- Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28Beneficial Microbes, 2012
- Obesity and DyslipidemiaMedical Clinics of North America, 2011
- Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro FindingsInternational Journal of Molecular Sciences, 2010
- Evaluating the glucose tolerance test in miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceJCI Insight, 2008
- An Improved, Single Step Standardized Method of Lipid Extraction from Human Skeletal Muscle TissueAnalytical Letters, 2006
- Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences of the United States of America, 2005
- Management of Obesity as a Chronic Disease: Nonpharmacologic, Pharmacologic, and Surgical OptionsObesity Research, 2002
- Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).JCI Insight, 1997